首页> 美国卫生研究院文献>other >Bone Marrow Concentrate Does Not Improve Osseous Integration of Osteochondral Allograft Transplants in the Knee: A Comparative Magnetic Resonance Imaging Analysis
【2h】

Bone Marrow Concentrate Does Not Improve Osseous Integration of Osteochondral Allograft Transplants in the Knee: A Comparative Magnetic Resonance Imaging Analysis

机译:骨髓浓缩液不能改善膝关节骨软骨移植的骨整合:比较磁共振成像分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objectives:Fresh osteochondral allograft transplantation (OCA), which transfers viable, mature hyaline cartilage and subchondral bone into full-thickness chondral defects, has demonstrated good long-term results in the knee. However, incomplete osseous trabecular integration of allograft bone with the host bone is correlated with inferior patient-reported outcomes (Williams et al, JBJS, 2007) and can lead to graft failure. As a result, augmentation of OCA with bone marrow aspirate concentrate (BMAC) has been hypothesized to improve osseous incorporation of the allograft compared to OCA alone. The purpose of this study was to compare the appearance of osseous integration at the host-graft junction on magnetic resonance imaging (MRI) in patients treated with BMAC+OCA versus patients treated with OCA alone.
机译:目的:新鲜的骨软骨同种异体移植(OCA)将可行的,成熟的透明软骨和软骨下骨转移到全层软骨缺损中,在膝关节中显示出良好的长期效果。然而,同种异体移植骨与宿主骨的骨小梁整合不全与患者报告的不良结果相关(Williams等,JBJS,2007),并可能导致移植失败。结果,与单独的OCA相比,已经假设用骨髓穿刺浓缩液(BMAC)增强OCA可以改善同种异体骨的骨吸收。这项研究的目的是比较接受BMAC + OCA治疗的患者与仅接受OCA治疗的患者在磁共振成像(MRI)上的宿主移植物交界处骨整合的外观。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号